Pharma Nord

The Views of 1,500 Patient Groups on the Pharmaceutical Industry and ESG (Environmental, Social, and Governance) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 14, 2022

Many of these patient groups feel that pharma companies could do much more to communicate their ESG strategies to patient groups.

Key Points: 
  • Many of these patient groups feel that pharma companies could do much more to communicate their ESG strategies to patient groups.
  • Other respondent patient groups acknowledge the potential of ESG to support companies' efforts at building more patient-centric measures of company performance.
  • - International blood-cancers patient group, Romania
    Looking to the future, many patient groups would like pharma companies to improve how they involve patient communities in defining patient-relevant ESG measures.
  • A significant number (140) of respondent patient groups offered their own criteria for pharma's ESG targets [details provided in the 'Pharma and ESG - the Patient Perspective' report].

Coenzyme Q10 Market Value to hit $1 Billion by 2026: Global Market Insights, Inc.

Retrieved on: 
Thursday, November 21, 2019

Coenzyme Q10 helps improve the nutritional value of food products and minimizes the occurrence of various health disorders.

Key Points: 
  • Coenzyme Q10 helps improve the nutritional value of food products and minimizes the occurrence of various health disorders.
  • Some key findings of the coenzyme Q10 market outlook report include:
    Consumption of dietary supplements across the globe is on rise owing to growing awareness towards nutritional enrichment in the diet which will spur the demand for coenzyme Q10.
  • Major players operating in the coenzyme Q10 market include DSM, Healthy Origins, Kaneka Corporation, SourceOne Global Partners and Pharmavite.
  • Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services.

Coenzyme Q10 Market Value to hit $1 Billion by 2026: Global Market Insights, Inc.

Retrieved on: 
Thursday, November 21, 2019

Coenzyme Q10 helps improve the nutritional value of food products and minimizes the occurrence of various health disorders.

Key Points: 
  • Coenzyme Q10 helps improve the nutritional value of food products and minimizes the occurrence of various health disorders.
  • Some key findings of the coenzyme Q10 market outlook report include:
    Consumption of dietary supplements across the globe is on rise owing to growing awareness towards nutritional enrichment in the diet which will spur the demand for coenzyme Q10.
  • Major players operating in the coenzyme Q10 market include DSM, Healthy Origins, Kaneka Corporation, SourceOne Global Partners and Pharmavite.
  • Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services.

Global Coenzyme Q10 Ingredients for Dietary Food Supplements Market - Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 6, 2019

The "Global Coenzyme Q10 Ingredients for Dietary Food Supplements Market, Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Coenzyme Q10 Ingredients for Dietary Food Supplements Market, Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • Coenzyme Q10, also known as ubiquinone, is a fat-soluble vitamin-like compound which acts as a cofactor and is required by large and complex enzymes to carry out their functions.
  • CoQ10 is available in three redox states: fully oxidized (ubiquinone), semiquinone (ubisemiquinone), and fully reduced (ubiquinol), of which ubiquinone is the most widely-used state in dietary supplements.
  • The region dominates the market of COQ10 ingredients in terms of both volume and value.